MOTS-c peptide is also known as:
- Mitochondrial open reading frame of the 12S rRNA type-c peptide
- Mitochondrial 12S rRNA-derived peptide
- MOTS-c16
- MOTS-c-16
- Mitochondrial peptide MOTS-c
- Mitochondrial open reading frame of the 12S rRNA gene, type c
MOTS-c peptide is a 16-amino-acid peptide that is encoded by the mitochondrial 12S rRNA gene. It is a relatively new peptide that was first discovered in 2013. MOTS-c peptide is produced in the mitochondria, the energy factories of the cell, and it is transported to the nucleus, where it regulates the expression of genes involved in metabolism and stress response.
MOTS-c peptide is a promising new therapeutic target for a variety of conditions, including obesity, type 2 diabetes, muscle wasting, osteoporosis, and neurodegenerative diseases. Research is ongoing to determine the safety and efficacy of MOTS-c peptide in humans and to develop new MOTS-c peptide formulations.
If you are considering taking MOTS-c peptide, it is important to talk to your doctor first. They can help you to determine if MOTS-c peptide is right for you and can monitor you for any side effects.
